Association Between Introduction of the 23-valent Pneumococcal Polysaccharide Vaccine (PPSV23) and Pneumonia Incidence and Mortality Among General Older Population in Japan: A Community-based Study
Background: With global aging, especially in Asia, preventing pneumonia among seniors is vital. The necessity of introducing pneumococcal vaccines among the elderly has been highlighted, but there is a paucity of community-based real-world evidence on their effect. Sera Town in Hiroshima Prefecture,...
Saved in:
| Main Authors: | Aya Sugiyama, Masaaki Kataoka, Kentaro Tokumo, Kanon Abe, Hirohito Imada, Bunlorn Sun, Golda Ataa Akuffo, Tomoyuki Akita, Shingo Fukuma, Noboru Hattori, Junko Tanaka |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Japan Epidemiological Association
2025-05-01
|
| Series: | Journal of Epidemiology |
| Subjects: | |
| Online Access: | https://www.jstage.jst.go.jp/article/jea/35/5/35_JE20240285/_pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A narrative review on the effectiveness of PPSV23 vaccination in adults in China
by: Weiyan Zhang, et al.
Published: (2025-12-01) -
A Phase 3 Randomized Trial Investigating the Safety, Tolerability, and Immunogenicity of V116, an Adult-Specific Pneumococcal Vaccine, Compared with PPSV23, in Adults ≥50 Years of Age (STRIDE-10)
by: Veronika Jotterand, et al.
Published: (2025-03-01) -
Immunogenicity, Safety, and Clinical Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine in Patients With Spondyloarthritis (Preliminary Data)
by: M. M. Baranova, et al.
Published: (2022-04-01) -
Immune persistence of a single dose of 23-valent pneumococcal polysaccharide vaccine: A 6-year follow-up
by: Lili Huang, et al.
Published: (2025-12-01) -
The Use of 23-Valent Pneumococcal Polysaccharide Vaccine in Patients with Rheumatoid Arthritis
by: M. S. Naumtseva, et al.
Published: (2015-08-01)